Gabriel A Rabinovich Selected Research

Galectin 1 (LGALS1)

1/2022	Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm.
1/2022	Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression.
1/2021	Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin.
1/2021	A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
1/2021	Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8+ regulatory T cells.
1/2021	Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities.
1/2021	Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment.
1/2021	Galectin-1 impacts on glucose homeostasis by modulating pancreatic insulin release.
2/2020	High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
8/2019	Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liver.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriel A Rabinovich Research Topics

Disease

94	Neoplasms (Cancer) 01/2022 - 01/2002
53	Inflammation (Inflammations) 06/2021 - 05/2002
20	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2002
11	Infections 01/2018 - 05/2002
9	Hypoxia (Hypoxemia) 01/2022 - 10/2012
8	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2008
7	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2011
7	Pathologic Processes 01/2018 - 05/2002
6	Lymphoma (Lymphomas) 02/2020 - 01/2002
5	Autoimmune Diseases (Autoimmune Disease) 12/2017 - 12/2004
4	Atherosclerosis 01/2022 - 06/2008
4	Disease Progression 10/2021 - 04/2006
4	Colitis 06/2021 - 05/2003
4	Melanoma (Melanoma, Malignant) 11/2020 - 04/2008
4	Carcinogenesis 08/2019 - 10/2012
4	Neuroinflammatory Diseases 12/2016 - 09/2009
4	Uveitis 01/2015 - 06/2005
4	Hodgkin Disease (Hodgkin's Disease) 07/2013 - 08/2007
3	Fibrosis (Cirrhosis) 10/2022 - 12/2013
3	Adenocarcinoma 01/2021 - 04/2007
3	Heart Failure 01/2018 - 01/2013
3	Prostatic Neoplasms (Prostate Cancer) 09/2017 - 01/2013
3	Spinal Cord Injuries (Spinal Cord Injury) 12/2016 - 01/2014
3	Parasitic Diseases (Parasitic Disease) 04/2016 - 01/2015
3	Thrombosis (Thrombus) 01/2015 - 04/2008
3	Reactive Arthritis (Reiter Disease) 02/2013 - 10/2010
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2011 - 02/2011
3	Hypersensitivity (Allergy) 01/2010 - 05/2002
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2021 - 07/2016
2	Chagas Disease (American Trypanosomiasis) 01/2021 - 01/2004
2	Glioma (Gliomas) 01/2020 - 08/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 07/2013
2	Triple Negative Breast Neoplasms 01/2019 - 12/2018
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019 - 07/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 12/2013
2	Rheumatoid Arthritis 01/2018 - 06/2009
2	Myocardial Infarction 01/2018 - 01/2013
2	Crohn Disease (Crohn's Disease) 01/2018 - 01/2016
2	Ulcerative Colitis 01/2018 - 01/2016
2	Celiac Disease (Celiac Sprue) 01/2018 - 11/2002
2	Multiple Sclerosis 12/2016 - 09/2015
2	Asthma (Bronchial Asthma) 01/2016 - 02/2006
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 06/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 07/2013
2	Infertility (Sterility) 07/2015 - 01/2011
1	Atrial Fibrillation 10/2022

Drug/Important Bio-Agent (IBA)

68	Galectin 1 (LGALS1)IBA 01/2022 - 01/2002
50	Galectins (Galectin)IBA 10/2022 - 01/2005
43	Polysaccharides (Glycans)IBA 01/2021 - 05/2006
38	LectinsIBA 01/2022 - 09/2002
37	Carrier Proteins (Binding Protein)IBA 01/2022 - 01/2002
33	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 01/2022 - 03/2004
16	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
13	CytokinesIBA 11/2020 - 06/2002
12	LigandsIBA 06/2021 - 04/2008
10	Galectin 3 (LGALS3)IBA 10/2022 - 01/2004
9	AntigensIBA 10/2021 - 12/2004
7	CarbohydratesIBA 10/2021 - 06/2002
7	Biological ProductsIBA 01/2016 - 01/2009
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 06/2008
5	Peptides (Polypeptides)IBA 01/2021 - 06/2005
5	AntibodiesIBA 01/2021 - 11/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
4	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2021 - 06/2014
4	beta-galactosideIBA 02/2007 - 01/2002
3	LipidsIBA 01/2022 - 01/2016
3	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 10/2021 - 10/2016
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	C-Type Lectins (C-Type Lectin)IBA 01/2021 - 06/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2014
3	Conditioned Culture MediaIBA 11/2020 - 04/2015
3	Retinaldehyde (Retinal)IBA 01/2020 - 04/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2012 - 01/2002
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2021 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2016
2	Protein Isoforms (Isoforms)IBA 10/2021 - 09/2014
2	Hormones (Hormone)IBA 01/2021 - 08/2019
2	EpitopesIBA 01/2021 - 01/2016
2	Monoclonal AntibodiesIBA 01/2021 - 12/2014
2	AlarminsIBA 01/2021 - 10/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 11/2020
2	Messenger RNA (mRNA)IBA 10/2018 - 02/2013
2	matrigelIBA 09/2017 - 02/2011
2	Interleukin-17 (Interleukin 17)IBA 01/2015 - 10/2010
2	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 03/2006
2	saccharide-binding proteinsIBA 09/2014 - 04/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2013 - 07/2011
2	recombinant human tumor necrosis factor-binding protein-1IBA 02/2013 - 12/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2013 - 12/2011
2	Pattern Recognition ReceptorsIBA 10/2011 - 02/2011
2	GlycoconjugatesIBA 08/2011 - 02/2009
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2010 - 11/2007
2	micaIBA 04/2008 - 11/2004
2	2-amino-3-chlorobutyric acidIBA 02/2007 - 01/2002
2	Immunoglobulin A (IgA)IBA 04/2006 - 11/2002
2	SugarsIBA 06/2002 - 01/2002

Therapy/Procedure

21	Therapeutics 01/2022 - 02/2006
12	Immunotherapy 01/2021 - 03/2004